XML 62 R43.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stock-Based Compensation [Abstract] |
Share-Based Payment Arrangement, Cost by Plan | Stock-based compensation expense for the years ended December 31, 2023, 2022 and 2021 is as follows:
| Year Ended December 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Stock options | $ | 900 |  |  | $ | 1,327 |  |  | $ | 2,001 |
Restricted share units(1) | 161,216 |  |  | 158,031 |  |  | 145,553 |
Total stock-based compensation expense | 162,116 |  |  | 159,358 |  |  | 147,554 |
Tax benefit recognized in the statements of earnings | 5,168 |  |  | 3,391 |  |  | 4,304 |
Stock-based compensation expense, net of tax | $ | 156,948 |  |  | $ | 155,967 |  |  | $ | 143,250 |
(1) Includes expense of $137.5 million, $143.2 million and $127.1 million for the years ended December 31, 2023, 2022 and 2021, respectively in stock compensation expense related to 8,096,595 common shares issued to the former owners of Acima, as part of the Aggregate Stock Consideration subject to restricted stock agreements, and recorded to Other charges in our Consolidated Statements of Operations. Shares issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings were not issued under the authorization of the 2021 Plan or any prior approved long-term incentive plan described above. See Note B and Note N for additional information.
Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity | Information with respect to stock option activity related to the Plans for the year ended December 31, 2023 follows:
| Equity Awards Outstanding |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value (in thousands)
Balance outstanding at January 1, 2023 | 854,339 |  |  | $ | 22.29 |  |  |  |  |
Granted | — |  |  | — |  |  |  |  |
Exercised | (137,473) |  |  | 17.36 |  |  |  |  |
Forfeited | (7,831) |  |  | 26.96 |  |  |  |  |
Expired | (53,392) |  |  | 33.49 |  |  |  |  |
Balance outstanding at December 31, 2023 | 655,643 |  |  | $ | 22.36 |  |  | 5.15 |  | $ | 8,223 |
Exercisable at December 31, 2023 | 552,733 |  |  | $ | 20.75 |  |  | 4.89 |  | $ | 7,617 |
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions | The weighted average fair values of the options granted under the Plans were calculated using the Black-Scholes method. There were no options granted in 2023 or 2022. The weighted average grant date fair value and weighted average assumptions used in the option pricing models for 2021 are as follows:
|  |  | Year Ended December 31,
|  |  | 2021 |  |
Weighted average grant date fair value |  |  | $ | 14.94 |  |  |
Weighted average risk free interest rate |  |  | 0.49 | % |  |
Weighted average expected dividend yield |  |  | 2.87 | % |  |
Weighted average expected volatility |  |  | 50.29 | % |  |
Weighted average expected life (in years) |  |  | 4.62 |  |
Schedule of Nonvested Restricted Stock Units Activity | Information with respect to non-vested restricted stock unit activity follows:
| Restricted Awards Outstanding |  | Weighted Average Grant Date Fair Value
Balance outstanding at January 1, 2023(1) | 5,177,485 |  |  | $ | 46.63 |
Granted | 968,045 |  |  | 30.05 |
Vested(2) | (3,742,784) |  |  | 48.71 |
Forfeited | (193,994) |  |  | 32.47 |
Balance outstanding at December 31, 2023(1) | 2,208,752 |  |  | $ | 37.10 |
(1) Includes 3,691,328 and 363,791 outstanding shares at January 1, 2023 and December 31, 2023, respectively, related to RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, described further in Note B, which were not issued under the authorization of the 2021 Plan or any previously approved long-term incentive plan described above. (2) Includes 3,327,537 shares vested during 2023 as part of RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, as described above.

X
- Definition Stock Based Compensation. + References No definition available. + Details
Name: | upbd_StockBasedCompensationAbstract
Namespace Prefix: | upbd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration